Dronedarone for the prevention of cardioversion

Details for Australian Patent Application No. 2009259009 (hide)

Owner Sanofi-Aventis

Inventors Radzik, Davide; Gaudin, Christophe; Van Eickels, Martin; Hamdani, Nacera

Agent A J Park

Pub. Number AU-A-2009259009

PCT Pub. Number WO2009/150535

Priority 08290531.6 10.06.08 EP; 61/060,260 10.06.08 US

Filing date 8 June 2009

Wipo publication date 17 December 2009

International Classifications

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2009/150535 Priority application(s): WO2009/150535

3 March 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read 08290531.6 10 Jun 2008 EP and 61/060,263 10 Jun 2008 US and amend the invention title to read Dronedarone for the Prevention of Permanent Atrial Fibrillation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259015-Methods and means of increasing the water use efficiency of plants

2009259008-Dronedarone for the prevention of cardioversion